Peter Levitch is a world-renowned expert in FDA regulations. Mr. Levitch has held senior positions managing the regulatory and clinical programs at Ortho Diagnostic Systems (a subsidiary of Johnson & Johnson) and has been an advisor to more than 200 leading biotechnology and biological firms, including: Amgen, Genentech, Immunex, DuPont, Baxter, J&J. Mr. Levitch's experience and familiarity with FDA related issues is a key asset to The Sage Group enabling him to accomplish capital conserving yet commercially efficient regulatory strategies and tactical programs. Mr. Levitch, in his years of activity in the health care field, especially in qualifying biotechnology derived products, will provide for The Sage Group what he has so successfully provided for other companies. The sales of the products so successfully assisted by Mr. Levitch have annual sales in the billions of dollars.